InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Perry Andrew, Directeur Commercial. Insider active across 1 company, notably G1 Therapeutics, Inc.. Aggregated, 2 filings have been logged. History available since 3 January 2022. The latest transaction was disclosed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
6,000 shares0Common StockSEC:0001562180-22-000308
6,000 shares0Common StockSEC:0001562180-22-000308:0
2 of 2 declarations
About Perry Andrew
Perry Andrew is the Chief Commercial Officer at G1 Therapeutics, Inc. In this role, he is responsible for the company's commercial strategy and sales. His expertise in business development is essential for the growth of G1 Therapeutics, Inc.
